Hemp company joins sports celebrities in lawsuit alleging fraud and money laundering — Inside the Tyson and Ric Flair case
Hemp company joins sports celebrities in lawsuit alleging fraud and money laundering, according to a 76-page complaint filed Dec. 19, 2025, in U.S. District Court in Illinois. The suit names LGNDS plus Mike Tyson and Ric Flair as plaintiffs. It also targets former Carma executives over alleged wire fraud, embezzlement and money laundering. The complaint claims defendants used celebrity likenesses outside licensing agreements. As a result, investors and partners reportedly lost funds and royalties.
Industry leaders should watch this case closely because it raises questions about branding, sublicensing and fiduciary duty. Moreover, the lawsuit details alleged self-dealing, improper sublicensing and unpaid loans tied to Tyson-branded products. LGNDS is described as a global hemp company working across delta-8 THC, hemp-derived delta-9 and CBD verticals. For brands, the suit signals risks in celebrity deals, unclear royalty structures and opaque corporate transfers. Therefore, companies should tighten licensing contracts, demand transparent audits and document transfers of celebrity IP.
Hemp company joins sports celebrities in lawsuit alleging fraud and money laundering
This lawsuit began with a 76-page complaint filed on Dec. 19, 2025, in U.S. District Court in Illinois. Plaintiffs include LGNDS, Mike Tyson and Ric Flair. Defendants are former Carma executives and a shareholder. The complaint alleges a conspiracy of wire fraud, embezzlement and money laundering. Therefore, the case centers on alleged misuse of celebrity licensing and corporate funds.
Key background points
- Parties involved include LGNDS, Carma, Mike Tyson and Ric Flair. Moreover, named defendants include Chad Bronstein, Adam Wilks, Nicole Cosby and James Case.
- Allegations claim unauthorized sublicensing of Tyson and Flair likenesses. As a result, partners and investors say they lost royalties and payments.
- LGNDS focused on hemp-derived cannabinoids such as delta-8, hemp-derived delta-9 and CBD. The company also pursued apparel and footwear licensing.
- The complaint mentions alleged self-dealing, excessive bonuses and transfers of Ric Flair IP without informed consent.
Hemp company joins sports celebrities in lawsuit alleging fraud and money laundering: why brands must pay attention
This sports celebrities lawsuit signals broader risk in the hemp industry. Brands face legal exposure when contracts lack clarity. For example, unclear royalty terms can trigger disputes and allegations of fraud. Therefore, companies should tighten licensing, audit financials and document transfers of IP.
Immediate implications for brands and investors
- Review licensing agreements for sublicensing clauses and royalty triggers.
- Demand transparent accounting and third-party audits, because money flows must be verifiable.
- Insist on clear transfer documentation when celebrity IP moves between entities.
- Consider escrow or milestone payments to reduce embezzlement risk.
For further reporting on the case see full coverage at The New York Sun and Yahoo News.
Evidence and case details: Hemp company joins sports celebrities in lawsuit alleging fraud and money laundering
The complaint was filed on Dec. 19, 2025 in U.S. District Court in Illinois. Plaintiffs include LGNDS, Mike Tyson and Ric Flair. Defendants named are Chad Bronstein, Adam Wilks, Nicole Cosby and James Case. According to press coverage, the 76 page complaint alleges a RICO conspiracy that includes wire fraud, embezzlement and money laundering. For reporting that summarizes the filing see The New York Sun and Yahoo.
The complaint lists specific fraud allegations and money laundering evidence. For example, it claims defendants used Tyson and Flair likenesses outside licensing agreements. Moreover, the suit alleges unauthorized sublicensing, self dealing and misrepresentation of Carma valuation to investors. The plaintiffs claim defendants granted themselves excessive compensation and bonuses, which reduced funds owed to partners and stakeholders.
Key pieces of alleged evidence include:
- Contracts and agreements that show rights to use Tyson and Flair likenesses and the terms of royalties.
- Transaction records and accounting entries that plaintiffs say reveal money laundering and unapproved transfers.
- Internal communications that reportedly describe self dealing and improper promotions.
- Corporate transfer documents related to Ric Flair IP that plaintiffs say lacked informed consent.
The complaint also details a 2022 deal to manufacture and market Tyson branded cannabis flower and pre rolls in return for royalties. Plaintiffs allege royalty payments were not made and that some obligations were waived in exchange for personal equity interests. As a result, plaintiffs say Carma extended largely unpaid loans to defendants. For international coverage of the case see Marca.
Financial claims and legal remedies are significant. Plaintiffs seek more than 50 million dollars in damages and demand a jury trial. Therefore, discovery will likely focus on bank records, loan documents and communications. Because the case alleges fraud and money laundering evidence, it may also trigger regulatory scrutiny and criminal referrals. Companies in the hemp industry should track developments closely, since these hemp lawsuit details could shape licensing and compliance practices going forward.
Quick reference: parties and allegations
Table: key parties and primary allegations at a glance.
| Party Name | Role | Allegation Type | Case Status |
|---|---|---|---|
| LGNDS | Miami-based hemp company, plaintiff | Alleges fraud, money laundering, RICO conspiracy, royalties withheld | Plaintiff; complaint filed Dec. 19, 2025; litigation pending |
| Mike Tyson | Sports celebrity, plaintiff | Claims unauthorized use of likeness, unpaid royalties | Plaintiff; litigation pending |
| Ric Flair | Sports celebrity, plaintiff | Claims unauthorized transfer of likeness, lack of informed consent | Plaintiff; litigation pending |
| Carma | Chicago-based branding company, plaintiff | Asserts fraud and self-dealing against former executives | Plaintiff; litigation pending |
| Chad Bronstein | Former Carma executive, defendant | Named for wire fraud, embezzlement, money laundering, self-dealing | Named defendant; answer pending |
| Adam Wilks | Former Carma executive, defendant | Named for wire fraud, embezzlement, improper sublicensing | Named defendant; answer pending |
| Nicole Cosby | Former Carma executive, defendant | Named for conspiracy, excessive compensation, misrepresentation | Named defendant; answer pending |
| James Case | Former Carma shareholder/executive, defendant | Named for RICO-related conduct and improper transfers | Named defendant; answer pending |
Note: Case status reflects the Dec. 19, 2025 filing in U.S. District Court in Illinois.
Conclusion
Hemp company joins sports celebrities in lawsuit alleging fraud and money laundering underscores liability in celebrity-brand deals. Plaintiffs assert wire fraud, embezzlement and money laundering in a 76-page complaint filed Dec. 19, 2025.
This case documents alleged unauthorized sublicensing, self-dealing, unpaid royalties and transfers of celebrity IP. Therefore, brands must tighten licensing terms, require transparent accounting and protect IP with clear transfer records. Brands should include audit rights and milestone payments in deals to reduce risk.
Because the complaint seeks substantial damages and exposes potential regulatory scrutiny, reputational risk is high. Moreover, investors and partners should insist on escrow arrangements and independent audits to limit embezzlement risks. Investors should demand clear valuations and independent audits before committing capital.
EMP0 and MyCBDAdvisor provide trusted resources for hemp compliance and cannabinoid information. For guidance and ongoing coverage visit MyCBDAdvisor. MyCBDAdvisor offers up-to-date reporting, compliance checklists and expert commentary to help brands navigate licensing, royalties and hemp industry regulation.
As the litigation unfolds, the hemp industry must prioritize transparency and stronger controls to rebuild public trust and safeguard future celebrity partnerships.
Frequently Asked Questions (FAQs)
What is this lawsuit about?
The hemp company joins sports celebrities in lawsuit alleging fraud and money laundering. Plaintiffs say defendants engaged in wire fraud, embezzlement and money laundering. They allege unauthorized sublicensing of Mike Tyson and Ric Flair likenesses. The complaint also cites unpaid royalties and self dealing. The filing seeks over 50 million dollars and a jury trial.
Who are the main parties involved?
Parties include:
- LGNDS, a Miami-based hemp company and plaintiff
- Mike Tyson, plaintiff and licensor of likeness rights
- Ric Flair, plaintiff with claims over IP transfers
- Carma, Chicago branding firm and plaintiff
- Chad Bronstein, Adam Wilks, Nicole Cosby, James Case listed as defendants
What evidence supports the fraud and money laundering claims?
The complaint cites contracts, transaction records, and internal communications. Moreover, it points to accounting entries that plaintiffs say show unapproved transfers. The 2022 Tyson manufacturing and royalty deal features prominently. Plaintiffs also allege excessive bonuses and undisclosed equity swaps.
How does this affect hemp brands and investors?
The sports celebrities lawsuit highlights licensing risks and reputational harm. Brands may face regulatory scrutiny and investor distrust. Therefore, companies should require clear royalties, third party audits, escrow arrangements and strict sublicensing language.
What should readers watch next?
Watch discovery, document production and any criminal referrals. Also monitor rulings on damages and injunctions. For ongoing coverage and compliance guidance follow trusted industry sources and legal filings.
